Loading summary
Transcript1 lines
- [00:00]
A
Public.com presents the rundown, your daily market update in under 10 minutes. My name is Zaidad Mani and Today is Monday, January 5th. In today's episode, we'll explain the impacts the events in Venezuela are having on the markets. We'll also tell you about the GLP1 weight loss pill that just went on sale today. Then stick around to the end of the show to find out why investors are paying close attention to this year's CES in Vegas. We got a great show for you today. Let's go. The first trading day of 2026 was a mixed one. On Friday, the S P 500 went up 0.2% while the Nasdaq was basically flat, technically dropping by 0.03%. And today is technically the final day of the Santa Claus rally window. So far, Santa has not delivered this year. The S P500 is down about 1% during this stretch and if we don't get a big rally today, this will be the third year in a row that the S P has dropp dropped during the Santa Claus rally period. But given how the markets performed in 2024 and 2025 going up double digits, a slow start to the year isn't anything to be concerned about. Now we did get some big news over the weekend that sparked some concern and could have an impact on the markets. The US Military conducted an operation in Venezuela and captured its leader Nicolas Maduro. It was pretty wild stuff to wake up to on Saturday morning. Now this news obviously increases geopolitical risk, but for now it's not having a major impact on the markets just yet. We are seeing the classic safe haven ass gold and silver prices rally this morning. But stocks are also in the green and pre market trading and oil prices are flat now. We'll talk more about the impact on the oil markets and energy companies in a bit. Zooming out though, we have some important economic data coming out this week. On Friday, the Bureau of Labor Statistics will release the December jobs report. This report will shed more light on the health of the labor market and could impact what the Federal Reserve decides to do with interest rates at their next meeting. And believe it or not, earnings season is also right around the corner. Major banks will start reporting earnings next week. So between the geopolitical tension, the job data and earning season knocking at the door, 2026 is wasting absolutely no time making some noise. As always, we're going to be staying on top of everything happening in the markets and breaking it down for you every morning. So make sure you guys are subscribed for the podcast to stay in the loop, let's run through some headlines, starting with the big geopolitical story everyone is talking about. Venezuela. Over the weekend, US Forces captured Venezuelan President Nicolas Maduro in the capital of Venezuela on the orders of President Trump. And historically, an event like that would have sent oil prices absolutely ripping higher. But this time, oil prices have barely moved, jumping less than 1% and still hovering around the 60 a barrel range. And the reason for that is pretty simple. There is an oversupply of oil. Right now, oil production in the US Is near record highs. OPEC plus countries haven't cut back on production and demand has been soft. And that's why oil prices right now are sitting at their lowest level in nearly five years. You added the fact that Venezuela doesn't produce as much oil as they used to. Despite having the largest oil reserves in the world right now, Venezuela produces less than 1% of the global oil supply. So even if Venezuelan output takes a hit from this geopolitical uncertainty, analysts say this can be easily offset by production elsewhere. But here's where things get a little interesting. Stocks of US Oil companies are surging this morning. Shares of Chevron, Exxon, ConocoPhillips and Oil Service giants like Halliburton and Baker Hughes are all moving higher this morning. And that's because President Trump said that American oil companies will be heavily involved in Venezuela's energy moving forward, spending billions of dollars to rebuild Venezuela's energy infrastructure and reviving their oil sector. Chevron is especially well positioned here. It's the only major US Oil company currently operating in Venezuela under a special sanctions waiver, producing roughly 20% of the country's output. So the biggest winner of these conflicts might be US Companies, but maybe not. See, before we get too carried away, you got to keep in mind that reviving Venezuela's oil industry will take years and cost upwards of $100 billion. And it also comes with massive political and legal risks. Plus, there's a ton of uncertainty on the future of Venezuela. And what's kind of ironic here is that if Venezuela does get back to producing a lot more oil like they did back in the day, that would add even more oil supply to the market, which would push down oil prices even more, which is great for consumers, but that's not great for oil companies. So we'll have to see what role US Oil companies play in the revival of Venezuela's oil industry. There's definitely a lot of uncertainty right now, but in the short term, markets aren't reacting the way that they have in the past. Let's shift gears and talk about GLP1s. The first ever GLP1 pill for obesity from Novo Nordisk is officially available for sale in the US just two weeks after getting the green light from the FDA. This new WeGovy pill is now available at more than 70,000 pharmacies including CVS and Costco, and also through online providers like RO and Weight Watchers. And I think this could be a game changer, not just because pills are more convenient than injections, but also the price point. The cash price for this pill will range from $149 to $299 per month to depending on the dose. That makes it one of the cheapest GLP1 options on the market, and it might be even cheaper for people with insurance. On top of that, this also launches the next phase of the GLP1 wars between Novo Nordisk and Eli Lilly. Earlier in 2025, Eli Lilly overtook Novo Nordisk as the market share leader for GLP1s. As of the end of Q3, Eli Lilly controls about 58% of the market while Novo Nordisk sits around 42%. That pushed up Eli Lilly's valuation to over $1 trillion while Nova Nordisk stock dropped more than 40 year. But this WeGovy pill gives Novo Nordis a first movers advantage since Eli Lilly is still waiting for their pill to get FDA approval now. There is one catch though. Novo Nordis pill requires patients to wait 30 minutes before eating or drinking after taking the pill. Eli Lilly's pill, at least so far, doesn't have any restrictions either way. The takeaway here is that Novo Nordisk is trying to win back market share from Eli Lilly and they're hoping this pill gives them the edge and zooming out. I think it's going to be a big year for the healthcare sector in general. If you want to learn more, go check out our weekend episode where I made predictions for 2026. One of my predictions was that healthcare sector would be the best performing sector in 2026. I just think the hype around the GLP1 pills, along with the innovations coming from AI are some reasons for that. If you want to hear my other predictions along with predictions from Mike and Connor, go check out the last episode. Mike had a spicy prediction in an epic rant that you guys need to hear. So go check that out if you missed it. Let's talk about some stocks making moves today. Shares of mobileye are popping this morning after the company landed an unnamed major US automaker a new customer. According to Reuters, this top 10American car maker will roll out Mobiley's next generation IQ6H self driving chip across a wide range of their vehicles. This deal pushes Mobileye's expected future deliveries of their IQ6H based driver assistance system to more than 19 million vehicles. Now a quick refresher on Mobileye. They are a self driving chip company that spun out of intel back in 2022. Now these days they're not just focused on autonomous driving, they're also focused on features like hands free highway driving, lane changes and traffic jam assistance which can be deployed today at scale. You know, a lot of cars have these advanced features these days and some of them are being powered by the Mobileye chip. As a result, Mobileye shares are up more than 6% this morning on this news. It's a nice bounce back for the company after losing half its value in 2025. Now on the flip side, Comcast stock is down 6% this morning after officially completing its cable spin off. As of this morning, Comcast's traditional cable networks, including cnbc, Ms. Now and the Golf Channel, now live inside a separate publicly traded company called Versant Media. Shares of both Comcast and Versant are down today as trading gets underway. Not really surprising to see that investors aren't bullish on the future of traditional cable. Let's wrap the show with the fun fact. CES kicks off this week and it could be an important one for tech investors. CES is the Consumer Electronics show, which happens in Vegas every January, and as a tech nerd, I get hyped for it every year. Now historically it's where companies show off giant TVs and wild concept cars and gadgets that may or may not ever hit the shelves. But this year CES will be all about AI hardware. According to earlier ports, we're going to see a ton of AI powered smart glasses and humanoid robots and I don't know, maybe AI powered washing machines and dishwashers too. But what investors will really be paying attention to are the big keynotes from companies like Nvidia, intel and amd, which are all happening today. Now all three stocks are already up this morning heading into the event, so we'll see if these companies actually show off anything new and interesting because there is a ton of hype building up for it. If anything interesting is reported, we'll obviously talk about it on the show tomorrow. And hopefully next year I'll be in Vegas to attend CES in person. It's something that I've always wanted to do what's funny is my wedding anniversary is also this week. It always lines up with ces and I can't think of a better way to celebrate a wedding anniversary than attending CES in Vegas. I just need to, you know, convince my wife that going to Vegas in January is better than going to Mexico or some tropical Caribbean island. You know, my wife reads the comments on Spotify and YouTube, so you guys back me up here. All right, well, all right, guys, that's the rundown for today. Hope you guys enjoyed today's episode. If you did and you have like five extra seconds, consider giving us a five star rating on Apple, Spotify, YouTube, wherever you listen to your podcast. And if you are listening on Spotify, don't forget to vote in today's Spotify poll. Leave us a comment on Spotify. All that engagement really does help us out and it helps other people find the show. Thank you guys so much for listening, watching, and commenting. Shout out to Mike and Connor for all the work behind the scenes and we'll see you guys back here tomorrow.